This factsheet reviews major sources of coverage for women residing in the U.S. in 2019, discusses the impact of the ACA on women’s coverage, and the coverage challenges that many women continue to face
- view as grid
- view as list
We analyzed data from the 2018 National Health Interview Survey (NHIS) and 2018 Behavioral Risk Factor Surveillance System (BRFSS) to calculate prevalence rates of declinable health conditions. This data note looks at the share of adults ages 18-64 with declinable pre-existing conditions, with a particular focus on women.
An overview of the Mexico City Policy, which requires foreign NGOs to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition for receiving most U.S. government global health assistance.
This brief examines what the loss of the Affordable Care Act (ACA) would mean for women’s coverage and access to health care.
This brief and side-by-side tables reviews the key health issues that are likely to have a direct impact on women’s health as well as their access to coverage and care, and summarizes the presidential candidates’ stated positions and records on these issues.
Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019
This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines its current application. Since enacted in 1985, Kemp-Kasten has often been used to withhold funding from the United Nations Population Fund (UNFPA).
The U.S. Government and International Family Planning & Reproductive Health: Statutory Requirements and Policies
This fact sheet summarizes the major statutory requirements and policies pertaining to U.S. global family planning/reproductive health (FP/RH) efforts over time and identifies those currently in effect, including the Mexico City Policy and the Kemp-Kasten Amendment.
During COVID-19, incidence and risk of intimate partner violence (IPV) has increased. This post describes some policy options to support IPV survivors and providers.
This brief presents additional analysis of a recent KFF Coronavirus Poll, conducted between March 11 and 15, 2020 and finds larger shares of women are worrying about the negative consequences of the coronavirus and taking greater precautions than men.